Alar Pharmaceuticals (Taiwan) Today

6785 Stock  TWD 151.50  2.00  1.34%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 37

 
High
 
Low
Below Average
Alar Pharmaceuticals is selling for under 151.50 as of the 22nd of November 2024; that is 1.34% up since the beginning of the trading day. The stock's lowest day price was 151.5. Alar Pharmaceuticals has about a 37 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Alar Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of October 2024 and ending today, the 22nd of November 2024. Click here to learn more.
Alar Pharmaceuticals Inc. operates as a drug development company. The company was founded in 2016 and is based in Taichung, Taiwan. ALAR PHARMACEUTICALS operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan OTC Exchange. The company has 57 M outstanding shares. More on Alar Pharmaceuticals

Moving together with Alar Stock

  0.874114 Synmosa BiopharmaPairCorr
  0.646576 Foresee PharmaceuticalsPairCorr
  0.886620 Handa PharmaceuticalsPairCorr
  0.766539 DV BiomedPairCorr

Moving against Alar Stock

  0.842360 Chroma ATEPairCorr
  0.782610 China AirlinesPairCorr
  0.742345 Accton Technology CorpPairCorr
  0.653533 LotesPairCorr
  0.630057 Fubon MSCI TaiwanPairCorr
  0.610050 YuantaP shares TaiwanPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Alar Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Alar Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Alar Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business ConcentrationDrug Manufacturers—Specialty & Generic, Healthcare (View all Sectors)
Alar Pharmaceuticals (6785) is traded on Taiwan OTC Exchange in Taiwan and employs 19 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.98 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Alar Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Alar Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Alar Pharmaceuticals operates under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 57 M outstanding shares. Alar Pharmaceuticals has accumulated about 556.12 M in cash with (71.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.76.
Check Alar Pharmaceuticals Probability Of Bankruptcy

Alar Pharmaceuticals Risk Profiles

Although Alar Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Alar Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.

Alar Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Alar Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Bollinger Bands Now

   

Bollinger Bands

Use Bollinger Bands indicator to analyze target price for a given investing horizon
All  Next Launch Module

Additional Tools for Alar Stock Analysis

When running Alar Pharmaceuticals' price analysis, check to measure Alar Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alar Pharmaceuticals is operating at the current time. Most of Alar Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Alar Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alar Pharmaceuticals' price. Additionally, you may evaluate how the addition of Alar Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.